s*n
2 楼
k*4
3 楼
here is the reason, wonder how true it is.
the USA Today appears to have jumped the gun with an article suggesting the
FDA has ok'd VIVUS's (Nasdaq: VVUS) Qnexa, which will be marketed under
Qsymia.
A new prescription diet drug OK'd today by the government is expected to
help heavy patients drop about 10% of their weight — more than any other
approved obesity medication.
The article appears to have been inadvertent posted early, as the FDA
decision has yet been announced. It was taken down at the USA Today's main
site, although it is was syndicated to others and is still live. Nonetheless
, investors in VVUS are using the article as an excuse to bid up the stock.
After trading down 27 percent earlier today, shares are now up 1.9 percent.
【在 a*********r 的大作中提到】
: 可以考虑买进其一或BOTH了吗？
the USA Today appears to have jumped the gun with an article suggesting the
FDA has ok'd VIVUS's (Nasdaq: VVUS) Qnexa, which will be marketed under
Qsymia.
A new prescription diet drug OK'd today by the government is expected to
help heavy patients drop about 10% of their weight — more than any other
approved obesity medication.
The article appears to have been inadvertent posted early, as the FDA
decision has yet been announced. It was taken down at the USA Today's main
site, although it is was syndicated to others and is still live. Nonetheless
, investors in VVUS are using the article as an excuse to bid up the stock.
After trading down 27 percent earlier today, shares are now up 1.9 percent.
【在 a*********r 的大作中提到】
: 可以考虑买进其一或BOTH了吗？
h*o
4 楼
could this be approve with restriction?
the
Nonetheless
【在 k**********4 的大作中提到】
: here is the reason, wonder how true it is.
: the USA Today appears to have jumped the gun with an article suggesting the
: FDA has ok'd VIVUS's (Nasdaq: VVUS) Qnexa, which will be marketed under
: Qsymia.
: A new prescription diet drug OK'd today by the government is expected to
: help heavy patients drop about 10% of their weight — more than any other
: approved obesity medication.
: The article appears to have been inadvertent posted early, as the FDA
: decision has yet been announced. It was taken down at the USA Today's main
: site, although it is was syndicated to others and is still live. Nonetheless
the
Nonetheless
【在 k**********4 的大作中提到】
: here is the reason, wonder how true it is.
: the USA Today appears to have jumped the gun with an article suggesting the
: FDA has ok'd VIVUS's (Nasdaq: VVUS) Qnexa, which will be marketed under
: Qsymia.
: A new prescription diet drug OK'd today by the government is expected to
: help heavy patients drop about 10% of their weight — more than any other
: approved obesity medication.
: The article appears to have been inadvertent posted early, as the FDA
: decision has yet been announced. It was taken down at the USA Today's main
: site, although it is was syndicated to others and is still live. Nonetheless
k*4
5 楼
most likely it is, if it is indeed approved.
【在 h***o 的大作中提到】
: could this be approve with restriction?
:
: the
: Nonetheless
【在 h***o 的大作中提到】
: could this be approve with restriction?
:
: the
: Nonetheless
h*o
6 楼
from the context it has to be that, I don't believe USA today could make a
mistake
like this.
【在 k**********4 的大作中提到】
: most likely it is, if it is indeed approved.
mistake
like this.
【在 k**********4 的大作中提到】
: most likely it is, if it is indeed approved.
k*4
7 楼
i m not sure. Usually they have to be prepared for
both scenarios, so the newspaper will be printed
in time. I dont believe FDA would notify a newspaper
first.
【在 h***o 的大作中提到】
: from the context it has to be that, I don't believe USA today could make a
: mistake
: like this.
both scenarios, so the newspaper will be printed
in time. I dont believe FDA would notify a newspaper
first.
【在 h***o 的大作中提到】
: from the context it has to be that, I don't believe USA today could make a
: mistake
: like this.
相关阅读